
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 24, 2024, titled "Zydus receives WHO prequalification for Miltefosine formulationand AP".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 24, 2024, titled "Zydus receives WHO prequalification for Miltefosine formulationand AP".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences